 | Up a level |
Ribi, Karin; Pagan, Eleonora; Sala, Isabella; Ruggeri, Monica; Bianco, Nadia; Bucci, Eraldo Oreste; Graffeo, Rossella; Borner, Markus; Giordano, Monica; Gianni, Lorenzo; Rabaglio, Manuela; Freschi, Andrea; Cretella, Elisabetta; Seles, Elena; Farolfi, Alberto; Simoncini, Edda; Ciccarese, Mariangela; Rauch, Daniel; Favaretto, Adolfo; Glaus, Agnes; ... (2023). Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland. Journal of Cancer Survivorship, 17(6), pp. 1847-1858. Springer 10.1007/s11764-022-01222-y
Bana, Marika; Ribi, Karin; Peters, Solange; Kropf-Staub, Susanne; Zürcher-Florin, Sabin; Näf, Ernst; Stoffel, Barbara; Blaeuer, Cornelia; Borner, Markus; Malin, Diana; Biber, Rebecca; Betticher, Daniel; Kuhn-Bächler, Trudy; Cantoni, Nathan; Seeger, Thomas; Bütikofer, Lukas; Eicher, Manuela (2021). Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment: A Cluster-Randomized Study (Symptom Navi Pilot Study). Cancer nursing, 44(6), E687-E702. Wolters Kluwer 10.1097/NCC.0000000000000995
Wörmann, Bernhard; Bokemeyer, Carsten; Burmeister, Thomas; Köhne, Claus-Henning; Schwab, Matthias; Arnold, Dirk; Blohmer, Jens-Uwe; Borner, Markus; Brucker, Sara; Cascorbi, Ingolf; Decker, Thomas; de Wit, Maike; Dietz, Andreas; Einsele, Hermann; Eisterer, Wolfgang; Folprecht, Gunnar; Hilbe, Wolfgang; Hoffmann, Jürgen; Knauf, Wolfgang; Kunzmann, Volker; ... (2020). Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper. Oncology research and treatment, 43(11), pp. 628-636. Karger 10.1159/000510258
Rothschild, Sacha I; Betticher, Daniel; Zenhäusern, Reinhard; Anchisi, Sandro; von Moos, Roger; Pless, Miklos; Moosmann, Peter; Popescu, Razvan A; Calderoni, Antonello; Dressler, Marco; Rauch, Daniel; Pederiva, Stefanie; Woelky, Regina; Papet, Claudia; Bühler, Vera; Borner, Markus (2019). Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer chemotherapy and pharmacology, 84(4), pp. 881-889. Springer 10.1007/s00280-019-03927-x
Pestalozzi, Bernhard C; Tausch, Christoph; Dedes, Konstantin J; Rochlitz, Christoph; Zimmermann, Stefan; von Moos, Roger; Winterhalder, Ralph; Ruhstaller, Thomas; Mueller, Andreas; Buser, Katharina; Borner, Markus; Novak, Urban; Nussbaum, Catrina Uhlmann; Seifert, Bettina; Bigler, Martin; Bize, Vincent; Vilei, Simona Berardi; Rageth, Christoph; Aebi, Stefan (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC cancer, 17(1), p. 265. BioMed Central 10.1186/s12885-017-3261-1
Helbling, Melina; Lukesch, Anne Carolin; Haimovici, Aladin; Karamitopoulou, Evanthia; Berger, Martin Dave; Hädrich, Marion; Mallaev, Makhmud; Schnüriger, Beat; Kölzer, Viktor; Dawson, Heather; Borner, Markus; Langer, Rupert; Rosenberg, Robert; Nitsche, Ulrich; Inderbitzin, Daniel; Lugli, Alessandro; Tschan, Mario; Zlobec, Inti (2014). Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients. OncoTarget, 5(13), pp. 4671-4682. Impact Journals LLC
Kölzer, Viktor H.; Lugli, Alessandro; Dawson, Heather; Hädrich, Marion; Berger, Martin D.; Borner, Markus; Mallaev, Makhmudbek; Galván Hernández, José Alberto; Amsler, Jennifer; Schnüriger, Beat; Zlobec, Inti; Inderbitzin, Daniel (2014). CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. Journal of translational medicine, 12(81), p. 81. BioMed Central 10.1186/1479-5876-12-81
Zlobec, Inti; Borner, Markus; Lugli, Alessandro; Inderbitzin, Daniel (2012). Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients. International journal of surgical oncology, 2012, p. 795945. New York, N.Y.: Hindawi 10.1155/2012/795945
Karamitopoulou, Eva; Zlobec, Inti; Tornillo, Luigi; Carafa, Vincenza; Schaffner, Thomas; Brunner, Thomas; Borner, Markus; Diamantis, Ioannis; Zimmermann, Arthur; Terracciano, Luigi (2010). Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology, 42(3), pp. 229-34. London: Wolters Kluwer Lippincott Williams & Wilkins 10.3109/00313021003631379
Karamitopoulou, Eva; Pallante, Pierlorenzo; Zlobec, Inti; Tornillo, Luigi; Carafa, Vincenza; Schaffner, Thomas; Borner, Markus; Diamantis, Ioannis; Esposito, Francesco; Brunner, Thomas; Zimmermann, Arthur; Federico, Antonella; Terracciano, Luigi; Fusco, Alfredo (2010). Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. European journal of cancer, 46(8), pp. 1438-44. Amsterdam: Elsevier 10.1016/j.ejca.2010.01.033
Dufour, Jean-François; Hoppe, Hanno; Heim, Markus H; Helbling, Beat; Maurhofer, Olivier; Szucs-Farkas, Zsolt; Kickuth, Ralph; Borner, Markus; Candinas, Daniel; Saar, Bettina (2010). Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. Oncologist, 15(11), pp. 1198-204. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2010-0180
Ruhstaller, Thomas; Templeton, Arnoud; Ribi, Karin; Schuller, Jan C; Borner, Markus; Thierstein, Sandra; von Moos, Roger; Pederiva, Stefanie; Lohri, Andreas; Lombriser, Norbert; von Briel, Christian; Koeberle, Dieter; Popescu, Razvan (2010). Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02). Onkologie, 33(5), pp. 222-8. Basel: Karger 10.1159/000305094
Koeberle, Dieter; Montemurro, Michael; Samaras, Panagiotis; Majno, Pietro; Simcock, Mathew; Limacher, Andreas; Lerch, Stefanie; Kovàcs, Katalin; Inauen, Roman; Hess, Vivianne; Saletti, Piercarlo; Borner, Markus; Roth, Arnaud; Bodoky, György (2010). Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). Oncologist, 15(3), pp. 285-92. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2009-0316
Cmelak, Anthony J; Lordick, Florian; Borner, Markus; Goldberg, Richard M; Saif, M Wasif (2009). Management of infusion reactions in clinical trials and beyond: the US and EU perspectives. Oncology, 23(2 Suppl 1), pp. 18-25. Norwalk, Conn.: UBM Medica
Ribi, Karin; Koeberle, Dieter; Schuller, Jan C; Honegger, Hanspeter; Roth, Arnaud; Hess, Viviane; Moosmann, Peter; von Moos, Roger; Borner, Markus; Lombriser, Norbert; Pestalozzi, Bernhard; Ruhstaller, Thomas (2009). Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? Supportive care in cancer, 17(8), pp. 1109-1116. Berlin: Springer 10.1007/s00520-008-0570-6
Karamitopoulou, Eva; Tornillo, Luigi; Zlobec, Inti; Cioccari, Lukas; Carafa, Vincenza; Borner, Markus; Schaffner, Thomas; Brunner, Thomas; Diamantis, Ioannis; Zimmermann, Arthur; Terracciano, Luigi (2008). Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. American journal of clinical pathology, 130(5), pp. 780-6. Chicago, Ill.: American Society for Clinical Pathology 10.1309/AJCP35FDCAVANWMM
Wagner, Oliver J; Inglin, Roman A; Bisch-Knaden, Sonja; Mettler, Daniel; Borner, Markus; Candinas, Daniel; Egger, Bernhard (2008). Sirolimus and intraoperative hyperthermic peritoneal chemoperfusion with mitomycin-C do not impair healing of bowel anastomoses. Transplant international, 21(6), pp. 554-63. Oxford: Wiley-Blackwell 10.1111/j.1432-2277.2007.00635.x
Koeberle, Dieter; Saletti, Piercarlo; Borner, Markus; Gerber, Daniela; Dietrich, Daniel; Caspar, Clemens B; Mingrone, Walter; Beretta, Kurt; Strasser, Florian; Ruhstaller, Thomas; Mora, Oreste; Herrmann, Richard (2008). Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology, 26(22), pp. 3702-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2008.16.5704
Salzberg, Marc; Rochlitz, Christoph; Morant, Rudolf; Thalmann, George; Pedrazzini, Augusto; Roggero, Enrico; Schönenberger, Astrid; Knuth, Alexander; Borner, Markus (2007). An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer. Onkologie, 30(7), pp. 355-60. Basel: Karger 10.1159/000102452
Tscharner, Gion Gudench; Bühler, Sabine; Borner, Markus; Hunziker, Thomas (2006). Grover's disease induced by cetuximab. Dermatology, 213(1), pp. 37-9. Basel: Karger 10.1159/000092836
Salzberg, Marc; Borner, Markus; Bauer, Jean-Alexandre; Morant, Rudolf; Rauch, Daniel; Rochlitz, Christoph (2006). Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients. European journal of cancer, 42(15), pp. 2660-1. Amsterdam: Elsevier 10.1016/j.ejca.2006.06.009
Tschan, Mario; Fischer, K. M.; Fung, V. S.; Pirnia Borner, Farzaneh; Borner, Markus; Fey, Martin; Tobler, Andreas; Torbett, B. E. (2003). Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns. Journal of biological chemistry, 278(44), pp. 42750-42760. American Society for Biochemistry and Molecular Biology 10.1074/jbc.M307067200
Kölzer, Viktor; Zlobec, Inti; Cathomas, Marionna Myrta; Dirschmid, Klaus; Offner, Felix; Puppa, Giacomo; Tornillo, Luigi; Berger, Martin Dave; Borner, Markus; Dawson, Heather; Hädrich, Marion; Mallaev, Makhmudbek; Schnüriger, Beat; Inderbitzin, Daniel; Lugli, Alessandro (1 September 2014). A multicentre inter-observer study on tumour budding using a 10HPF method in colorectal cancer: a study from the Swiss Association of Gastrointestinal Pathology (SAGIP) (Unpublished). In: European Congress of Pathology 2014. London, UK. 30.08.-03.09.2014.
Dawson, Heather; Hädrich, Marion; Kölzer, Viktor; Borner, Markus; Mallaev, M.; Schnüriger, Beat; Inderbitzin, Daniel; Zlobec, Inti; Lugli, Alessandro (2013). Intratumoral budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastasis in colon and rectal cancer patients. Pathologe, 34(6), p. 602. Springer-Medizin-Verlag
Koeberle, Dieter; Betticher, Daniel; Von Moos, Roger; Dietrich, Daniel; Brauchli, Peter; Baertschi, Daniela; Matter-Walstra, Klazien; Winterhalder, Ralph; Borner, Markus; Anchisi, Sandro; Moosmann, Peter; Kollár, Attila; Saletti, Piercarlo; Roth, Arnaud; Frueh, Martin; Kueng, Marc; Popescu, Razvan; Schacher, Sabina; Hess, Viviane and Herrmann, Richard (2013). O-0028 Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial. Annals of oncology, 24(Suppl 4), iv22-iv22. Oxford University Press 10.1093/annonc/mdt201.28
Lugli, Alessandro; Hädrich, Marion; Inderbitzin, D; Borner, Markus; Zlobec, Inti (2012). Intratumoral budding is preoperative biopsies predicts local and distant metastasis in colorectal cancer patients. Virchows Archiv, 461(1 (Sup), S11. Springer
